Hospitalized adult patients with 2009 influenza A(H1N1) in Beijing, China: risk factors for hospital mortality

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Xi, Xiuming ^a   Xu, Yuan ^b   Jiang, Li ^a   Li, Ang ^c   Duan, Jie ^d   Du, Bin ^e  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d Beijing Health School   (China)

^e PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; CORTICOSTEROID; HYPERTENSIVE FACTOR; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; OSELTAMIVIR; ANTIINFLAMMATORY AGENT;

ACUTE KIDNEY FAILURE; ACUTE RESPIRATORY FAILURE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHINA; CHRONIC LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; COUGHING; DIABETES MELLITUS; DRUG MEGADOSE; DYSPNEA; FEMALE; HOSPITALIZATION; HUMAN; INFLUENZA A (H1N1); LACTATE DEHYDROGENASE BLOOD LEVEL; LENGTH OF STAY; LEUKOCYTE COUNT; LEUKOCYTOSIS; LEUKOPENIA; LOW DRUG DOSE; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYALGIA; OUTCOME ASSESSMENT; PANDEMIC INFLUENZA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; SEPTIC SHOCK; SORE THROAT; TREATMENT RESPONSE; INFLUENZA; INFLUENZA VIRUS A H1N1; ISOLATION AND PURIFICATION; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VIROLOGY;

ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS; CHINA; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 77957004957     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-256     Document Type: Article

References (34)

1. Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep 2009, 58:467-470.
2. Update: infections with a swine-origin influenza A (H1N1) virus - United States and other countries, April 28, 2009. MMWR Morb Mortal Wkly Rep 2009, 58:431-433.
3. Naffakh N, van der Werf SV. April 2009: an outbreak of swine-origin influenza A (H1N1) virus with evidence for human-to-human transmission. Microbes Infect 2009, 11:725-728. 10.1016/j.micinf.2009.05.002, 19442755.
4. Influenza A (H1N1) - update 14. Geneva: World Health Organization, 2009. , http://www.who.int/csr/don/2009_05_04a/en/index.html
5. Transmission dynamics and impact of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec 2009, 84:481-484.
6. Estadísticas: influenza A (H1N1). Mexico City: Secretaria de Salud, May 29, 2009. , http://portal.salud.gob.mx/contenidos/noticias/influenza/estadisticas.html
7. Jain S, Kaminoto L, Bramley A, Schmitz A, Benoit S, Louie J, Sugerman D, Druckenmiller J, Ritger K, Chugh R, Jasuja S, Deutscher M, Chen S, Walker J, Duchin J, Lett S, Soliva S, Wells E, Swerdlow D, Uyeki T, Fiore A, Olsen S, Fry A, Bridges C, Finelli L, . the 2009 Pandemic Influenza A(H1N1) Virus Hospitalizations Investigation Team Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009, 361:1935-1944. 10.1056/NEJMoa0906695, 19815859, the 2009 Pandemic Influenza A(H1N1) Virus Hospitalizations Investigation Team.
8. Cao B, Li X-W, Mao Y, Wang J, Liu H-Z, Chen Y-S, Liang Z-A, Liang L, Zhang S-J, Zhang B, Gu L, Lu L-H, Wang D-Y, Wang C, . National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009, 361:2507-2517. 10.1056/NEJMoa0906612, 20007555, National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China.
9. Domínguez-Cherit G, Lapinsky S, Macias A, Pinto R, Espinosa-Perez L, de la Torre A, Poblano-Morales M, Baltazar-Torres J, Bautisata E, Martinez A, Martinez M, Rivero E, Valdez R, Ruiz-Palacios G, Hernandez M, Stewart T, Fowler R. Critically Ill patients with 2009 influenza A (H1N1) in Mexico. JAMA 2009, 302:1880-1887. 10.1001/jama.2009.1536, 19822626.
10. Kumar A, Zarychanski R, Pinto R, Cook D, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, Turgeon A, Lapinsky S, Ahern S, Smith O, Siddiqui F, Jouvet P, Kuwaja K, McIntyre L, Menon K, Hutchison J, Hornstein D, Joffe A, Lauzier F, Singh J, Karachi T, Wiebe K, Olafson K, Ramsey C, Sharma S, Dodek P, Meade M, Hall R, Fowler R, . for the Canadian Critical Care Trials Group H1N1 Collaborative Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009, 302:1872-1879. 10.1001/jama.2009.1496, 19822627, for the Canadian Critical Care Trials Group H1N1 Collaborative.
11. Global Alert and Response (GAR) - Pandemic (H1N1) guidance documents. World Health Organization Web site. , http://www.who.int/csr/resources/publications/swineflu/en/.
12. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
13. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710. 10.1007/BF01709751, 8844239.
14. Nguyen-Van-Tam JS, Openshaw PJM, Hashim A, Gadd E, Lim WS, Semple MG, Read RC, Taylor BL, Brett SJ, McMenamin J, Enstrone JE, Armstrong C, Nicholson KG, . on behalf of the Influenza Clinical Information Network (FLU-CIN) Risk factors for hospitalization and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May - September 2009). Thorax 2010, 65:645-651. 10.1136/thx.2010.135210, 2921287, 20627925, on behalf of the Influenza Clinical Information Network (FLU-CIN).
15. Denholm JT, Gordon CL, Johnson PD, Hewagama SS, Stuart RL, Aboltins C, Jeremiah C, Knox J, Lane GP, Tramontana AR, Slavin MA, Schulz TR, Richards M, Birch CJ, Cheng AC. Hospitalised adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia. MJA 2010, 192:84-86.
16. The ANZIC Influenza Investigators Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009, 361:1925-1934. 10.1056/NEJMoa0908481, 19815860, The ANZIC Influenza Investigators.
17. Morgan OW, Bramley A, Fowlkes A, Freedman DS, Taylor TH, Gargiullo P, Belay B, Jain S, Cox C, Kaminoto L, Flore A, Finelli L, Olsen SJ, Fry AM. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A (H1N1) disease. PLoS One 2010, 5:e9694. 10.1371/journal.pone.0009694, 2837749, 20300571.
18. Campbell A, Rodin R, Kropp R, Mao Y, Hong Z, Vachon J, Spika J, Pelletier L. Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. CMAJ 2010, 182:349-355. 2831689, 20159893.
19. Hanslik T, Boelle P, Flahault A. Preliminary estimation of risk factors for admission to intensive care units and for death in patients infected with A(H1N1) 2009 influenza virus, France 2009-2010. PLoS Curr Influenza 2010, RRN1150. 2836028, 20228857.
20. Echevarria-Zuno S, Mejia-Arangure JM, Mar-Obeso AJ, Grajales-Muniz C, Robles-Perez E, Gonzalez-Leon M, Ortega-Alvarez MC, Gonzalez-Bonilla C, Rascon-Pacheco RA, Borja-Aburto VH. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009, 374:2072-2079. 10.1016/S0140-6736(09)61638-X, 19913290.
21. Bagshaw SM, Egi M, George C, Bellomo R, . Australia New Zealand Intensive Care Society Database Management Committee Early blood glucose control and mortality in critically ill patients in Australia. Crit Care Med 2009, 37:463-470. 10.1097/CCM.0b013e318194b097, 19114915, Australia New Zealand Intensive Care Society Database Management Committee.
22. Chen CY, Lee CH, Liu CY, Wang JH, Wang LM, Perng RP. Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome. J Chin Med Assoc 2005, 68:4-10. 10.1016/S1726-4901(09)70124-8, 15742856.
23. Leong HN, Earnest A, Lim HH, Chin CF, Tan CSH, Puhaindran ME, Tan ACH, Chen MIC, Leo YS. SARS in Singapore - predictors of disease severity. Ann Acad Med Singapore 2006, 35:326-331.
24. Chan JC, Tsui EL, Wong VC, . Hospital Authority SARS Collaborative Group Prognostication in severe acute respiratory syndrome: a retrospective time-course analysis of 1312 laboratory-confirmed patients in Hong Kong. Respirology 2007, 12:531-542. 10.1111/j.1440-1843.2007.01102.x, 17587420, Hospital Authority SARS Collaborative Group.
25. Writing committee of the WHO consultation on clinical aspects on pandemic (H1N1) 2009 influenza Clinical aspects of pandemic 2009 influenza A(H1N1) virus infection. N Engl J Med 2010, 362:1708-1719. 10.1056/NEJMra1000449, 20445182, Writing committee of the WHO consultation on clinical aspects on pandemic (H1N1) 2009 influenza.
26. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, Samuel MC, Rosenberg J, Talarico J, Hatch D, . California Pandemic (H1N1) Working Group Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009, 302:1896-1902. 10.1001/jama.2009.1583, 19887665, California Pandemic (H1N1) Working Group.
27. Chien YS, Su CP, Tsai HT, Huang AS, Lien CE, Hung MN, Chuang JH, Kuo HS, Chang SC. Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan. J Infect 2010, 60:168-174. 10.1016/j.jinf.2009.12.012, 20036689.
28. Gomersall CD, Kargel MJ, Lapinsky SE. Pro/con clinical debate: Steroids are a key component in the treatment of SARS. Crit Care 2004, 8:105-107. 10.1186/cc2452, 420028, 15025770.
29. World Health Organization WHO guidelines for pharmacological management of pandemic influenza A(H1N1) 2009 and other influenza viruses. Revised February 2010. World Health Organization., http://www.who.int/csr/resources/publications/swineflu/h1n1_use_antivirals_20090820/en/index.html
30. Auyeung TW, Lee JS, Lai WK, Choi CH, Lee HK, Lee JS, Li PC, Lok KH, Ng YY, Wong WM, Yeung YM. The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study. J Infect 2005, 51:98-102. 10.1016/j.jinf.2004.09.008, 16038758.
31. Liem NT, Tung CV, Hien ND, Hien TT, Chau NQ, Long HAT, Hien NT, Mai le Q, Taylor WR, Wertheim H, Farrar J, Khang DD, Horby P. Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clin Infect Dis 2009, 48:1639-1646. 10.1086/599031, 19435433.
32. Lee N, Chan PK, Hui DS, Rainer TH, Wong E, Choi KW, Lui GC, Wong BC, Wong RY, Lam WY, Chu IM, Lai RW, Cockram CS, Sung JJ. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009, 200:492-500. 10.1086/600383, 19591575.
33. Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004, 39:1300-1306. 10.1086/425004, 15494906.
34. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003, 289:76-79. 10.1001/jama.289.1.76, 12503980.